IL284006B2 - Mitochondria-targeting peptides - Google Patents

Mitochondria-targeting peptides

Info

Publication number
IL284006B2
IL284006B2 IL284006A IL28400621A IL284006B2 IL 284006 B2 IL284006 B2 IL 284006B2 IL 284006 A IL284006 A IL 284006A IL 28400621 A IL28400621 A IL 28400621A IL 284006 B2 IL284006 B2 IL 284006B2
Authority
IL
Israel
Prior art keywords
compound
amino
mmol
group
pct
Prior art date
Application number
IL284006A
Other languages
English (en)
Hebrew (he)
Other versions
IL284006A (en
IL284006B1 (en
Original Assignee
Stealth Biotherapeutics Corp
Stealth Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Corp, Stealth Biotherapeutics Inc filed Critical Stealth Biotherapeutics Corp
Publication of IL284006A publication Critical patent/IL284006A/en
Publication of IL284006B1 publication Critical patent/IL284006B1/en
Publication of IL284006B2 publication Critical patent/IL284006B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL284006A 2018-12-18 2019-11-19 Mitochondria-targeting peptides IL284006B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862781153P 2018-12-18 2018-12-18
US201962892939P 2019-08-28 2019-08-28
PCT/US2019/062283 WO2020131282A1 (en) 2018-12-18 2019-11-19 Mitochondria-targeting peptides

Publications (3)

Publication Number Publication Date
IL284006A IL284006A (en) 2021-08-31
IL284006B1 IL284006B1 (en) 2024-08-01
IL284006B2 true IL284006B2 (en) 2024-12-01

Family

ID=71101606

Family Applications (2)

Application Number Title Priority Date Filing Date
IL284006A IL284006B2 (en) 2018-12-18 2019-11-19 Mitochondria-targeting peptides
IL314309A IL314309B2 (en) 2018-12-18 2019-11-19 Mitochondria-targeted peptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL314309A IL314309B2 (en) 2018-12-18 2019-11-19 Mitochondria-targeted peptides

Country Status (8)

Country Link
US (2) US12404300B2 (cg-RX-API-DMAC7.html)
EP (1) EP3898652A4 (cg-RX-API-DMAC7.html)
JP (1) JP7614092B2 (cg-RX-API-DMAC7.html)
CN (1) CN113544138B (cg-RX-API-DMAC7.html)
AU (1) AU2019403856B2 (cg-RX-API-DMAC7.html)
CA (1) CA3123368A1 (cg-RX-API-DMAC7.html)
IL (2) IL284006B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020131282A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11332499B2 (en) 2018-08-16 2022-05-17 Regents Of The University Of Minnesota Cyclic peptides and methods of use thereof
CN113544138B (zh) 2018-12-18 2024-10-29 隐形生物治疗公司 线粒体靶向肽
WO2020131283A1 (en) 2018-12-18 2020-06-25 Stealth Biotherapeutics Corp. Analogs that target mitochondrial diseases
CN118955233B (zh) * 2024-07-27 2025-05-06 康龙化成手性医药技术(宁波)有限公司 一种单取代双环[1.1.1]戊烷(bcp)的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2656854T1 (sl) * 2003-02-04 2015-09-30 Cornell Research Foundation, Inc. Uporabe aromatsko-kationskega peptida
EP2808029A3 (en) * 2010-03-15 2015-04-01 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
CN103249423A (zh) 2010-07-09 2013-08-14 康肽德生物医药技术有限公司 预防或治疗缺血/再灌注损伤之后无复流的方法
EP2606022A2 (en) * 2010-08-16 2013-06-26 Santhera Pharmaceuticals (Schweiz) AG Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
US8383919B2 (en) * 2010-12-14 2013-02-26 Xueyun Gao Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof
CA2839408A1 (en) * 2011-06-14 2012-12-20 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CA2858550A1 (en) * 2011-12-09 2013-06-13 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CA2865409C (en) * 2012-02-23 2020-07-21 Cornell University Aromatic-cationic peptides and uses of same
WO2017093897A1 (en) 2015-11-30 2017-06-08 Peter Schiller Aromatic-cationic peptides conjugated to antioxidants and their use in treating complex regional pain syndrome
US10870678B2 (en) * 2016-04-11 2020-12-22 Arcuate Therapeutics, Inc. Chiral peptides
CN113544138B (zh) 2018-12-18 2024-10-29 隐形生物治疗公司 线粒体靶向肽
WO2020131283A1 (en) 2018-12-18 2020-06-25 Stealth Biotherapeutics Corp. Analogs that target mitochondrial diseases

Also Published As

Publication number Publication date
JP2022511939A (ja) 2022-02-01
IL314309B1 (en) 2025-05-01
US20260055136A1 (en) 2026-02-26
CA3123368A1 (en) 2020-06-25
IL284006A (en) 2021-08-31
JP7614092B2 (ja) 2025-01-15
EP3898652A4 (en) 2022-08-24
IL284006B1 (en) 2024-08-01
CN113544138A (zh) 2021-10-22
US12404300B2 (en) 2025-09-02
KR20210093957A (ko) 2021-07-28
US20220041653A1 (en) 2022-02-10
AU2019403856A1 (en) 2021-06-24
IL314309B2 (en) 2025-09-01
EP3898652A1 (en) 2021-10-27
IL314309A (en) 2024-09-01
AU2019403856B2 (en) 2025-05-01
CN113544138B (zh) 2024-10-29
WO2020131282A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
JP7576670B2 (ja) ミトコンドリア標的化ペプチド
US20260055136A1 (en) Mitochondria-targeting peptides
JP7606966B2 (ja) ミトコンドリア病を標的とするアナログ
AU2020260489A1 (en) Chiral peptides
WO2021262710A1 (en) Prodrugs of mitochodria-targeting oligopeptides
CA3085772C (en) Mitochondria-targeting peptides
US20240059734A1 (en) Mitochondria-targeting peptides
HK40097183A (en) Mitochondria-targeting peptides
WO2021262708A1 (en) Prodrugs of mitochodria-targeting oligopeptides
HK40035078A (en) Mitochondria-targeting peptides
HK40035078B (en) Mitochondria-targeting peptides
HK40039982A (en) Mitochondria-targeting peptides